Your browser doesn't support javascript.
loading
Do We Have a Winner? Advocating for SBRT in HCC Management.
Safavi, Amir H; Dawson, Laura A; Mesci, Aruz.
Afiliação
  • Safavi AH; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
  • Dawson LA; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
  • Mesci A; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Clin Transl Radiat Oncol ; 45: 100740, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38380116
ABSTRACT
•Stereotactic body radiotherapy (SBRT) is a safe and effective locoregional therapy for inoperable patients with HCC.•SBRT compares favorably with other local therapies in terms of local control, survival, morbidity, and cost-effectiveness.•SBRT should be considered and discussed in multidisciplinary management of appropriate HCC patients.•Advances in SBRT and novel combinations with systemic therapy may further widen the therapeutic index in HCC.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Clin Transl Radiat Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Clin Transl Radiat Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá